June 3, 2014

Actavis last week announced that it has reached an agreement with Cephalon to settle all outstanding patent litigation associated with Actavis' generic version of Nuvigil (armodafinil tablets).

July 31, 2013

The Food and Drug Administration has given Lupin Pharmaceuticals tentative approval to two of its products, the company said Wednesday.

April 30, 2012

Mylan plans to start selling a generic version of a drug for sleep disorders starting in June 2016, under a deal with Teva announced Monday.

March 30, 2011

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

October 24, 2010

The Food and Drug Administration has approved risk evaluation and mitigation strategies for two sleep...

March 29, 2010

The Food and Drug Administration declined to approve a Cephalon drug as a treatment for...

January 10, 2010

Drug maker Cephalon and its French subsidiary sued generic drug maker Mylan in connection with...

January 5, 2010

Watson has filed an abbreviated new drug application for the generic version of a sleep...